PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

33 hedge funds and large institutions have $3.86M invested in Protalix BioTherapeutics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
-3
Holders Change %
-8.33%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
5
Calls
$6K
Puts
$188K
Net Calls
-$182K
Net Calls Change
-$123K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$139K
2
MWPCG
Measured Wealth Private Client Group
New Hampshire
+$17K
3
Group One Trading
Group One Trading
Illinois
+$7.81K
4
AA
Advisory Alpha
Michigan
+$2K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.75K

Top Sellers

1
OM
Opaleye Management
Massachusetts
-$777K
2
SAM
Sectoral Asset Management
Quebec, Canada
-$31K
3
Jane Street
Jane Street
New York
-$24K
4
Invesco
Invesco
Georgia
-$11K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$10.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
KPW
26
Kore Private Wealth
New York
$2K – – –
AA
27
Advisory Alpha
Michigan
$2K +$2K +500 New
OM
28
Opaleye Management
Massachusetts
– -$777K -250,000 Closed
SAM
29
Sectoral Asset Management
Quebec, Canada
– -$31K -9,967 Closed
Jane Street
30
Jane Street
New York
– -$24K -7,871 Closed
Invesco
31
Invesco
Georgia
– -$11K -3,596 Closed
Macquarie Group
32
Macquarie Group
Australia
– -$9K -2,910 Closed
1
2